Vertex, Inc.VERXNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank57
5Y CAGR-20.0%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
-20.0%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202525.57%
202414.52%
202339.01%
2022-4.86%
2021-19.00%
202077.83%
201928.63%
20180.00%